City of Hope names chief scientific officer

Duarte, Calif.-based City of Hope appointed John Carpten, PhD, director of the comprehensive cancer center, director of Beckman Research Institute of City of Hope and chief scientific officer.

Advertisement

Dr. Carpten is an internationally recognized expert in genome science, according to an April 6 health system news release. At City of Hope, he will also hold the Irell & Manella Cancer Center Director’s Distinguished Chair and the Morgan & Helen Chu Director’s Chair of the Beckman Research Institute.

Previously, Dr. Carpten was a professor and chair of the department of translational genomics at Los Angeles-based University of Southern California and associate director of its cancer center.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Executive Moves

  • Optum Rx has named Jon Bosland as its next chief financial officer. “The PBM space is at an inflection point…

  • Several women have recently stepped into new executive roles at hospitals and health systems — including through promotions, new appointments…

Advertisement

Comments are closed.